Published in Ann Pathol on January 01, 1990
Adult biphenotypic acute leukaemia: an entity with poor prognosis which is related to unfavourable cytogenetics and P-glycoprotein over-expression. Br J Haematol (1998) 1.44
Histological discrimination of idiopathic inflammatory bowel disease from other types of colitis. J Clin Pathol (1995) 1.43
Multicentric evaluation of the MDR phenotype in leukemia. French Network of the Drug Resistance Intergroup, and Drug Resistance Network of Assistance Publique-Hôpitaux de Paris. Leukemia (1997) 1.41
Schizophrenics know more than they can tell: probabilistic classification learning in schizophrenia. Psychol Med (2000) 1.28
Pgp and MRP activities using calcein-AM are prognostic factors in adult acute myeloid leukemia patients. Blood (1998) 1.21
The immunophenotype of 177 adults with acute myeloid leukemia: proposal of a prognostic score. Blood (2000) 1.12
Use of bronchoalveolar lavage in the evaluation of methotrexate lung disease. Thorax (1987) 1.11
Characteristics of platelet aggregation induced by the monoclonal antibody ALB6 (acute lymphoblastic leukemia antigen p 24). Inhibition of aggregation by ALB6Fab. FEBS Lett (1983) 0.99
Amiodarone-induced hypersensitivity pneumonitis. Evidence of an immunological cell-mediated mechanism. Chest (1984) 0.98
Reactivity of lymphocytes to a progesterone receptor-specific monoclonal antibody. Cell Immunol (1990) 0.97
Protein kinases in human leukemic cells. Am J Hematol (1985) 0.95
Acebutolol-induced hypersensitivity pneumonitis. Br Med J (Clin Res Ed) (1983) 0.89
JC-1: a very sensitive fluorescent probe to test Pgp activity in adult acute myeloid leukemia. Blood (2001) 0.88
Functional assay of multidrug resistant cells using JC-1, a carbocyanine fluorescent probe. Leukemia (1997) 0.86
Visual information processing in patients with schizophrenia: evidence for the impairment of central mechanisms. Neurosci Lett (2000) 0.85
Expression of the multidrug resistance-associated protein (MRP) mRNA and protein in normal peripheral blood and bone marrow haemopoietic cells. Br J Haematol (1996) 0.85
Immunohistochemical assessment and prognostic value of hepatitis B virus X protein in chronic hepatitis and primary hepatocellular carcinomas using anti-HBxAg monoclonal antibody. Pathol Oncol Res (2001) 0.84
Proapoptotic effects of antiestrogens, progestins and androgen in breast cancer cells. J Steroid Biochem Mol Biol (1999) 0.84
Category learning and perceptual categorization in schizophrenia. Schizophr Bull (1999) 0.83
Parallel induction of fibrinolysis and receptors for plasminogen and urokinase by interferon gamma on U937 cells. Biochem Biophys Res Commun (1988) 0.83
Differential requirement for p56lck in fetal and adult thymopoiesis. J Immunol (1998) 0.83
Overexpression of placental tissue protein 17b/TIP47 in cervical dysplasias and cervical carcinoma. Anticancer Res (2001) 0.81
Qualitative differences in effects of recombinant alpha-, beta- and gamma-interferons on human peripheral blood leukocytes in vitro. Ann Inst Pasteur Immunol (1986) 0.81
Temperature dependence of plasmin-induced activation or inhibition of human platelets. Blood (1991) 0.80
Cyclin D1 overexpression allows identification of an aggressive subset of leukemic lymphoproliferative disorder. Leukemia (1999) 0.80
High levels of P-glycoprotein activity in human lymphocytes in the first 6 months of life. Clin Pharmacol Ther (2008) 0.80
A new set of monoclonal antibodies against acute lymphoblastic leukemia. Leuk Res (1985) 0.80
Multidrug resistance gene expression in acute myeloid leukemia: major prognosis significance for in vivo drug resistance to induction treatment. Ann Hematol (1997) 0.80
[Botryoid rhabdomyosarcoma of the cervix. Clinico-pathologic study of a case]. Ann Pathol (1993) 0.79
Prognostic factors in elderly acute lymphoblastic leukaemia. Br J Haematol (1997) 0.79
Bone marrow lambda-type light chain crystalline structures associated with multiple myeloma. Virchows Arch A Pathol Anat Histopathol (1985) 0.79
Bone marrow one step fixation-decalcification in Lowy FMA solution: an immunohistological and in situ hybridization study. Pathol Res Pract (1994) 0.79
Peanut agglutinin. IV. A tool for studying human mononuclear cell differentiation. Scand J Immunol (1979) 0.79
Homeostasis of chemokines, interferon production and lymphocyte subsets: implications for AIDS pathogenesis. Biomed Pharmacother (1997) 0.79
Role of interleukin 2 receptor beta chain in initiating anti-CD3 and interleukin 2-induced proliferation of human resting T cells. Eur J Immunol (1990) 0.78
Mantle cell lymphoma, in leukaemic phase with prominent splenomegaly. A report of eight cases with similar clinical presentation and aggressive outcome. Virchows Arch (2000) 0.78
Lack of P-glycoprotein induction by rifampicin and phenobarbital in human lymphocytes. Int J Pharm (2010) 0.78
Both Pgp and MRP1 activities using calcein-AM contribute to drug resistance in AML. Adv Exp Med Biol (1999) 0.77
[Testing basic visual functions in the evaluation of extrapyramidal side effects of antipsychotic agents]. Orv Hetil (1998) 0.77
Evolutionary stability of fibrinogen epitopes implicated in fibrin polymerization and in fibrinolysis. Blood Coagul Fibrinolysis (1990) 0.77
Model for quantitative immunohistochemical assessment of pulpal response to biomaterials. J Biomed Mater Res (1997) 0.77
Smoking, CD45R0+ (memory), and CD45RA+ (naive) CD4+ T cells. Am Rev Respir Dis (1993) 0.77
[Creation of monoclonal antibodies against tumor necrosis factor-alpha (TNF-alpha) and transforming growth factor alpha (TFG-alpha), their definition and possible use]. Orv Hetil (1993) 0.77
[Expression of macrophage markers in childhood and adult Langerhans histiocytosis (LCH)]. Orv Hetil (1997) 0.77
Lymph node reaction patterns in patients with AIDS or AIDS-related complex. Curr Top Pathol (1991) 0.77
Role of active center and lysine binding sites of plasmin in plasmin-induced platelet activation and disaggregation. Thromb Haemost (1991) 0.76
Abstraction is impaired at the perceptual level in schizophrenic patients. Neurosci Lett (1998) 0.76
Measuring multidrug resistance expression in human malignancies: elaboration of consensus recommendations. Semin Hematol (1997) 0.75
T-cell depletion does not affect long-term human bone marrow culture. Bone Marrow Transplant (1987) 0.75
[Polyhydramnios and congenital cystic adenomatoid malformation of the fetal lung]. Orv Hetil (1983) 0.75
[Malignant histiocytosis of the intestinal tract. Difficulties in clinical differentiation between malignant histiocytosis and histiocytic lymphoma]. Orv Hetil (1984) 0.75
[Lymphoblastic leukemia and immunological markers]. Ann Med Interne (Paris) (1987) 0.75
[Malignant peripheral T-cell lymphomas: morphologic and immunopathologic bases of the classification proposed by Lennert and Suchi]. Ann Med Interne (Paris) (1988) 0.75
[Acute nonmyeloid leukemia in adults. Study of membrane antigens and terminal transferase. Diagnostic and prognostic value]. Presse Med (1985) 0.75
PHA-induced blast colonies and kinetic parameters in acute myeloid leukemia. Leuk Res (1982) 0.75
[Malignant lymphoblastic lymphoma associated with terminal reactive histiocytosis]. Morphol Igazsagugyi Orv Sz (1984) 0.75
[Regional cerebral blood flow changes in schizophrenic patients detected by SPECT studies under resting and active conditions]. Orv Hetil (1999) 0.75
Non epidermotropic cutaneous lymphoma ending in leukemia. A case of adult T cell lymphoma (ATL) in France? Pathol Res Pract (1986) 0.75
[Diagnostic alveolar lavage in alveolar proteinosis: cellularity and lymphocyte subpopulations]. Presse Med (1986) 0.75
[Angioimmunoblastic lymphadenopathy (AIL) and malignant T-lymphoma of AIL type]. Rev Med Interne (1988) 0.75
[Fiat lux!]. Rev Med Interne (2004) 0.75
[Prion dementias: nosology and diagnostic difficulties in the spectrum of Creutzfeld-Jakob encephalopathy]. Orv Hetil (1997) 0.75
[Hydrops foetalis not caused by isoimmunization]. Orv Hetil (1983) 0.75
[Histopathological changes in the spleen in malignant non-Hodgkin's lymphoma]. Morphol Igazsagugyi Orv Sz (1982) 0.75
[Adenomyomatosis of the gallbladder]. Orv Hetil (1999) 0.75
Screening monoclonal antibodies against cell-surface antigens. High frequency of natural antibodies. Scand J Immunol (1986) 0.75
Peripheral T-cell lymphoma presenting as hypereosinophilia with vasculitis. Am J Med (1988) 0.75
[Action of radiation of the head on the capacity for lymphoblastic transformation in the adult rabbit]. C R Acad Sci Hebd Seances Acad Sci D (1977) 0.75
Reversible translocation of glycoprotein Ib in plasmin-treated platelets: consequences for platelet function. Eur J Clin Invest (1993) 0.75
[Demonstration of lysozyme in malignant histiocytosis by the indirect immunoperoxidase method]. Morphol Igazsagugyi Orv Sz (1982) 0.75
In vitro depletion of clonogenic cells in adult acute lymphoblastic leukemia with a CD10 (anti-cALLA) monoclonal antibody. Eur J Cancer Clin Oncol (1987) 0.75
Determination of ultrastructural peroxidases and immunologic membrane markers in the diagnosis of acute leukemias. Blood (1982) 0.75
[Intraductal mucin-secreting tumors of the pancreas. Nosologic discussion of two cases of villous tumor of Wirsung's duct and a case of mucinous ductal ectasia]. Ann Pathol (1994) 0.75
Assignment to chromosome 12 of the gene coding for the human cell surface antigen CD9(p24) using the monoclonal antibody ALB6. Ann Genet (1985) 0.75
Decreased lymphokine-activated killer cells in kidney transplant recipients. Correlation with a diminished number of CD3-/NKH1+ cells. Transplantation (1990) 0.75
[Developmental aspects of the lesions in peliosis hepatis in renal transplant patients]. Arch Anat Cytol Pathol (1984) 0.75
[Malignant histiocytosis: histopathological characteristics based on 3 cases]. Morphol Igazsagugyi Orv Sz (1984) 0.75
A possible role for specific "anergy" in immunologic hyporeactivity to donor stimulation in human kidney allograft recipients. Transplantation (1993) 0.75
Detection of binding sites for spiroperidol on leukemic cells: its value for the phenotype characterization of lymphoid leukemias. Leuk Res (1983) 0.75
[Acquired Willebrand factor deficiency associated with monoclonal IgG kappa gammapathy. Presence of an inhibitor of ristocetin co-factor (author's transl)]. Nouv Presse Med (1981) 0.75
[Bronchoalveolar lavage]. Ann Pathol (1990) 0.75
[Ameloblastomas causing extensive mandibular defects treated by autologous transplantation]. Fogorv Sz (1983) 0.75
[Extrapulmonary mycobacterial infection with multiple cold abscesses]. Ann Pathol (1995) 0.75
[Ultrastructural peroxidases and immunological markers in acute adult leukaemia: therapeutic applications (author's transl)]. Nouv Presse Med (1982) 0.75
[Reactive hemophagocytotic syndrome simulating malignant histiocytosis]. Orv Hetil (1984) 0.75
[Acute malignant myelofibrosis. Report of 3 cases]. Arch Anat Cytol Pathol (1991) 0.75
Pentasomy 13q in a case of acute myelogenous leukemia (Mo). Cancer Genet Cytogenet (1998) 0.75
Method for rapid detection of membrane antigens by immunofluorescence and its application to screening monoclonal antibodies. Methods Enzymol (1986) 0.75
Comel-Netherton syndrome: evolution of manifestation in a 20-year follow-up and phenotypic overlap with peeling skin syndrome type B. Acta Derm Venereol (2000) 0.75
The effect of ultraviolet B light on antigen-presenting cells: implications for transfusion-induced sensitization. Semin Hematol (1992) 0.75
Evaluation of residual disease in human leukemias. Rev Fr Transfus Immunohematol (1985) 0.75
[A specific marker of thrombolysis: DDE complex]. C R Acad Sci III (1987) 0.75
[Malignant T lymphomas]. Pathol Biol (Paris) (1989) 0.75
[Systematic screening for Sjögren's syndrome in patients with various blood diseases]. Sem Hop (1979) 0.75
[Peripheral T-cell malignant lymphomas. Clinical, morphologic and developmental features in 22 cases]. Presse Med (1990) 0.75
Gastrointestinal cytoprotection: from basic science to clinical perspectives. Inflammopharmacology (2007) 0.75
A rapid method for detection of membrane antigens by immunofluorescence and its application to screening hybridoma antibodies. J Immunol Methods (1983) 0.75
Persistence of bone marrow lymphocytosis after induction treatment in common acute lymphoblastic leukemia. Marker analysis and significance. Cancer (1986) 0.75
[Monoclonal antibodies against surface antigens of lymphoblasts and blood cells or bone marrow recognize constituents of the human nephron]. Nephrologie (1984) 0.75
A latex immunoassay of fibrin/fibrinogen degradation products in plasma using a monoclonal antibody. Thromb Res (1986) 0.75